Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | runt-related transcription factor 1 | Starlite/ChEMBL | No references |
Homo sapiens | isocitrate dehydrogenase 1 (NADP+), soluble | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | core-binding factor, beta subunit | No references | |
Homo sapiens | synuclein, alpha (non A4 component of amyloid precursor) | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | hyperpolarization activated cyclic | 0.0023 | 0.0083 | 0.023 |
Brugia malayi | LBP / BPI / CETP family, N-terminal domain containing protein | 0.0213 | 0.3756 | 0.3756 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0019 | 0.0001 | 0.0002 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0798 | 0.0798 |
Echinococcus granulosus | cyclic nucleotide gated cation channel | 0.0023 | 0.0083 | 0.023 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0118 | 0.1915 | 0.5322 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0473 | 0.1315 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0473 | 0.5 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0473 | 0.0473 |
Onchocerca volvulus | 0.0213 | 0.3756 | 0.2747 | |
Loa Loa (eye worm) | hypothetical protein | 0.0102 | 0.1613 | 0.1613 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.3598 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0001 | 0.0002 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0091 | 0.1391 | 0.778 |
Onchocerca volvulus | 0.0213 | 0.3756 | 0.2747 | |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0473 | 0.1315 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.2426 | 0.2426 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0001 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0473 | 0.5 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0001 | 0.0002 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0034 | 0.0292 | 0.0813 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.2426 | 0.2426 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0118 | 0.1915 | 0.1915 |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.0122 | 0.1996 | 0.1996 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.2426 | 0.2426 |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.0122 | 0.1996 | 0.1996 |
Echinococcus multilocularis | cyclic nucleotide gated cation channel | 0.0023 | 0.0083 | 0.023 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0473 | 0.1315 |
Loa Loa (eye worm) | hypothetical protein | 0.0091 | 0.1391 | 0.1391 |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 0.1996 | 0.1996 |
Loa Loa (eye worm) | hypothetical protein | 0.0535 | 1 | 1 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0019 | 0.0001 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0798 | 0.0798 |
Echinococcus multilocularis | potassium:sodium hyperpolarization activated | 0.0023 | 0.0083 | 0.023 |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 0.1996 | 0.1996 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0019 | 0.0001 | 0.5 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0019 | 0.0001 | 0.5 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0019 | 0.0001 | 0.5 |
Echinococcus multilocularis | voltage gated potassium channel | 0.0034 | 0.0292 | 0.0813 |
Loa Loa (eye worm) | runx1 | 0.0067 | 0.0931 | 0.0931 |
Loa Loa (eye worm) | cyclic-nucleotide gated cation channel | 0.0023 | 0.0083 | 0.0083 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0118 | 0.1915 | 0.5322 |
Echinococcus granulosus | voltage gated potassium channel | 0.0034 | 0.0292 | 0.0813 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0083 | 0.0083 |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0023 | 0.0083 | 0.023 |
Onchocerca volvulus | 0.0213 | 0.3756 | 0.2747 | |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 0.1996 | 0.1996 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0292 | 0.0292 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0473 | 0.1315 |
Brugia malayi | isocitrate dehydrogenase | 0.0019 | 0.0001 | 0.0001 |
Brugia malayi | hypothetical protein | 0.0122 | 0.1996 | 0.1996 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0798 | 0.0798 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0122 | 0.1996 | 0.1996 |
Brugia malayi | Cyclic-nucleotide gated cation channel | 0.0023 | 0.0083 | 0.0083 |
Onchocerca volvulus | 0.0213 | 0.3756 | 0.2747 | |
Echinococcus granulosus | hyperpolarization activated cyclic | 0.0023 | 0.0083 | 0.023 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0001 | 0.0002 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0001 | 0.0002 |
Echinococcus multilocularis | hyperpolarization activated cyclic | 0.0023 | 0.0083 | 0.023 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0019 | 0.0001 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0429 | 0.0429 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0473 | 0.5 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0213 | 0.3756 | 0.3756 |
Schistosoma mansoni | lozenge | 0.0067 | 0.0931 | 0.2589 |
Brugia malayi | LBP / BPI / CETP family, N-terminal domain containing protein | 0.0213 | 0.3756 | 0.3756 |
Onchocerca volvulus | 0.0535 | 1 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 0.1996 | 0.1996 |
Onchocerca volvulus | 0.0213 | 0.3756 | 0.2747 | |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0001 | 0.5 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0019 | 0.0001 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0091 | 0.1391 | 0.1391 |
Onchocerca volvulus | 0.0213 | 0.3756 | 0.2747 | |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0019 | 0.0001 | 0.0001 |
Loa Loa (eye worm) | hypothetical protein | 0.0213 | 0.3756 | 0.3756 |
Brugia malayi | Isocitrate dehydrogenase | 0.0019 | 0.0001 | 0.0001 |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0023 | 0.0083 | 0.023 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0473 | 0.5 |
Onchocerca volvulus | 0.0122 | 0.1996 | 0.0702 | |
Schistosoma mansoni | hyperpolarization activated cyclic nucleotide-gated potassium channel | 0.0023 | 0.0083 | 0.023 |
Onchocerca volvulus | 0.0122 | 0.1996 | 0.0702 | |
Echinococcus granulosus | cyclic nucleotide gated cation channel | 0.0023 | 0.0083 | 0.023 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.011 | 0.1764 | 1 |
Onchocerca volvulus | 0.0213 | 0.3756 | 0.2747 | |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.011 | 0.1764 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0034 | 0.0292 | 0.0813 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0019 | 0.0001 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0535 | 1 | 1 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0122 | 0.1996 | 0.1996 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0129 | 0.2125 | 0.5905 |
Loa Loa (eye worm) | cyclic-nucleotide gated cation channel | 0.0023 | 0.0083 | 0.0083 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0122 | 0.1996 | 0.1996 |
Echinococcus multilocularis | cyclic nucleotide gated cation channel alpha 3 | 0.0023 | 0.0083 | 0.023 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0798 | 0.0798 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0429 | 0.1191 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0034 | 0.0292 | 0.0813 |
Loa Loa (eye worm) | hypothetical protein | 0.0091 | 0.1391 | 0.1391 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0118 | 0.1915 | 0.1915 |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0023 | 0.0083 | 0.023 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0034 | 0.0292 | 0.0813 |
Echinococcus granulosus | geminin | 0.0205 | 0.3598 | 1 |
Echinococcus granulosus | hyperpolarization activated cyclic | 0.0023 | 0.0083 | 0.023 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0019 | 0.0001 | 0.0002 |
Echinococcus multilocularis | geminin | 0.0205 | 0.3598 | 1 |
Brugia malayi | Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog | 0.0034 | 0.0292 | 0.0292 |
Onchocerca volvulus | 0.0213 | 0.3756 | 0.2747 | |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 0.1996 | 0.1996 |
Brugia malayi | hypothetical protein | 0.0091 | 0.1391 | 0.1391 |
Echinococcus granulosus | cyclic nucleotide gated cation channel alpha 3 | 0.0023 | 0.0083 | 0.023 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0023 | 0.0083 | 0.023 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0129 | 0.2125 | 0.5905 |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.0213 | 0.3756 | 0.3756 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.3598 | 1 |
Brugia malayi | LBP/BPI | 0.0091 | 0.1391 | 0.1391 |
Schistosoma mansoni | hyperpolarization activated cyclic nucleotide-gated potassium channel | 0.0023 | 0.0083 | 0.023 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0429 | 0.0429 |
Echinococcus multilocularis | Protein lozenge | 0.0067 | 0.0931 | 0.2589 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0019 | 0.0001 | 0.0002 |
Loa Loa (eye worm) | hypothetical protein | 0.0091 | 0.1391 | 0.1391 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0001 | 0.5 |
Brugia malayi | hypothetical protein | 0.0122 | 0.1996 | 0.1996 |
Echinococcus granulosus | potassium:sodium hyperpolarization activated | 0.0023 | 0.0083 | 0.023 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | > 31.5 uM | PUBCHEM_BIOASSAY: HTS Dose response counterscreen for assays utilizing the enzyme, b-galactosidase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1777, AID1778, AID1785, AID1786, AID2284, AID2285, AID2348, AID2352, AID2357, AID2359, AID2370, AID2420, AID2478, AID2491, AID2492, AID2493, AID2495, AID2497, AID2498, AID2500, AID434981, AID449737, AID463105, AID485352, AID488822, AID488842, AID488935] | ChEMBL. | No reference |
EC50 (functional) | = 43.18 um | PUBCHEM_BIOASSAY: E3 Ligase dose-response_384. (Class of assay: confirmatory) [Related pubchem assays: 1444 (E3 Ligase_dose response), 1442 (E3 Ligase_dose response), 1230 (E3 Ligase HTS_1536)] | ChEMBL. | No reference |
IC50 (functional) | 7.799 uM | PUBCHEM_BIOASSAY: Discovery of Small Molecule Probes for H1N1 Influenza NS1A. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504399] | ChEMBL. | No reference |
IC50 (functional) | > 31.5 uM | PUBCHEM_BIOASSAY: uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1777, AID1785, AID1786, AID1966, AID2136, AID2285, AID2495, AID434981, AID463105, AID488826, AID488935] | ChEMBL. | No reference |
IC50 (functional) | > 32 uM | PUBCHEM_BIOASSAY: HTS Image-Based Screen for Selective Antagonists of the KOR Receptor. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1777, AID1778, AID1785, AID1786, AID2284, AID2285, AID2348, AID2352, AID2357, AID2359, AID2370, AID2420, AID2478, AID2491, AID2492, AID2493, AID2495, AID2497, AID2498, AID2500, AID434981, AID449737, AID463105, AID488822, AID488842, AID488935] | ChEMBL. | No reference |
Potency (functional) | 1.4125 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 2.0787 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 2.0787 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 2.8184 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 3.1623 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.2643 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | 3.5481 uM | PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375] | ChEMBL. | No reference |
Potency (functional) | 3.9811 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 5.0119 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.8048 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.9433 uM | PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.581 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PubChem BioAssay. qHTS for Inhibitors of TGF-b: CCL64 Cells Orthogonal Assay for Cherry Picks. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.